Onc Now | Episode 30
In this episode of Onc Now, Catherine Glass speaks with thoracic oncology expert Professor Nicolas Girard about the evolving landscape of lung cancer treatment. They discuss current standards of care, practice-changing research, and the impact of precision medicine and immunotherapy on patient outcomes. Girard also shares insights from ongoing studies at Institut Curie and offers his vision for the future of thoracic oncology.
Apple | Spotify | Amazon Music | Youtube (25 mins)
Speaker bio:
Nicolas Girard is Head of Medical Oncology at Institut Curie, Paris, and a world-renowned specialist in thoracic oncology. His work has significantly advanced understanding and treatment of lung cancer, with a focus on precision medicine and clinical trial innovation.
Timestamps:
00:00 – Introduction
0:54 – Origin of interest in thoracic oncology
02:30 – Current standard treatments for lung cancer
05:17 – Practice-changing studies in this space
06:28 – Current research initiatives at Institut Curie
08:00 – Genomics and biomarker-driven therapies
09:30 – Optimising immunotherapy for different patient populations
11:10 – Importance of lung cancer screening
13:28 – Three magic wishes for healthcare
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
